|
| 37530920 | An Imbalance of Pathophysiologic Factors in Late Postprandial Hypoglycemia Post Bariatric Surgery: A Narrative Review. | | 2023 |
| 35466879 | Maternal Metabolic Health, Lifestyle, and Environment - Understanding How Epigenetics Drives Future Offspring Health. | | 2023 |
| 34776305 | The time is now for new, lower diabetes diagnostic thresholds. | Trends in Endocrinology and Metabolism | 2022 |
| 33776471 | The Diabetes Syndrome - A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms. | Int J Gen Med | 2021 |
| 34214188 | QUAREP-LiMi: A community-driven initiative to establish guidelines for quality assessment and reproducibility for instruments and images in light microscopy. | J Microsc | 2021 |
| 33116708 | Diabetes and Psoriasis: Different Sides of the Same Prism. | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2020 |
| 31843946 | Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC. | Diabetes Care | 2020 |
| 31414026 | Diabetic Gastroparesis: Perspectives From a Patient and Health Care Providers. | | 2019 |
| 31920963 | Diabetic Retinopathy-An Underdiagnosed and Undertreated Inflammatory, Neuro-Vascular Complication of Diabetes. | Frontiers in Endocrinology | 2019 |
| 31291183 | Type 2 diabetes: Evolving concepts and treatment. | | 2019 |
| 31419922 | Intersections and Clinical Translations of Diabetes Mellitus with Cancer Promotion, Progression and Prognosis. | Postgrad Med | 2019 |
| 30254083 | First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes. | Diabetes Care | 2018 |
| 28255241 | An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes. | | 2017 |
| 28958751 | Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes. | Progress in Cardiovascular Diseases | 2017 |
| 28629897 | A Unified Pathophysiological Construct of Diabetes and its Complications. | Trends Endocrinol Metab | 2017 |
| 28438156 | Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes. | BMC Med | 2017 |
| 27457644 | Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186. | Diabetes Care | 2016 |
| 26798148 | The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. | Diabetes Care | 2016 |
| 27042132 | Sodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metformin. | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2016 |
| 27210018 | Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profile. | | 2016 |
| 26854518 | Sodium-glucose cotransporter 2 inhibitors: an evidence-based practice approach to their use in the natural history of type 2 diabetes. | Current Medical Research and Opinion | 2016 |
| 27458683 | Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus. | | 2016 |
| 25913393 | Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies. | | 2015 |
| 25547241 | Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes. | | 2015 |
| 25786557 | THE RATIONALE FOR USE OF INCRETINS IN THE MANAGEMENT OF NEW ONSET DIABETES AFTER TRANSPLANTATION (NODAT). | Endocrine Practice | 2015 |
| 24918793 | Evidence-based practice use of incretin-based therapy in the natural history of diabetes. | | 2014 |
| 24459169 | Response to comment. Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? | Diabetes Care | 2014 |
| 25189437 | Overlap of genetic susceptibility to type 1 diabetes, type 2 diabetes, and latent autoimmune diabetes in adults. | Curr Diab Rep | 2014 |
| 24515252 | The use of non-insulin anti-diabetic agents to improve glycemia without hypoglycemia in the hospital setting: focus on incretins. | Current Diabetes Reports | 2014 |
| 25100362 | Use of incretin-based therapy in hospitalized patients with hyperglycemia. | Endocrine Practice | 2014 |
| 23614630 | A practice-based approach to the 2012 position statement of the American Diabetes Association and the European Association for the Study of Diabetes. | Current Medical Research and Opinion | 2013 |
| 23801800 | Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists! | Diabetes Care | 2013 |
| 23801791 | Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. | Diabetes Care | 2013 |
| 24432042 | Optimizing glycemic control and minimizing the risk of hypoglycemia in patients with type 2 diabetes. | Drugs in Context | 2013 |
| 23505191 | Measurement of waist circumference predicts coronary atherosclerosis beyond plasma adipokines. | Obesity (Silver Spring) | 2013 |
| 23393695 | Weight reduction in diabetes. | Advances in Experimental Medicine and Biology | 2012 |
| 21673295 | Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. | JAMA - Journal of the American Medical Association | 2011 |
| 21257006 | Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. | Am J Cardiol | 2011 |
| 21257004 | Comparison of high-density lipoprotein cholesterol to apolipoprotein A-I and A-II to predict coronary calcium and the effect of insulin resistance. | Am J Cardiol | 2011 |
| 21208675 | Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: a randomized controlled trial. | Diabetes Research and Clinical Practice | 2011 |
| 20303190 | Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women. | Int J Cardiol | 2011 |
| 20400045 | How to manage perioperative endocrine insufficiency. | Anesthesiology Clinics | 2010 |
| 21437091 | Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies. | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2010 |
| 21437092 | Pioglitazone for the treatment of type 2 diabetes in patients inadequately controlled on insulin. | Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy | 2010 |
| 21106867 | Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia. | Mayo Clinic Proceedings | 2010 |
| 20007922 | Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults? | Endocr Rev | 2010 |
| 19910501 | Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes. | Diabetes Care | 2010 |
| 19858063 | Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. | Endocrine Practice | 2009 |
| 19491209 | Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. | Diabetes | 2009 |
| 19665618 | Surgery in the patient with endocrine dysfunction. | Medical Clinics of North America | 2009 |